Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |